pulmicort and Hemosiderosis

pulmicort has been researched along with Hemosiderosis* in 4 studies

Reviews

1 review(s) available for pulmicort and Hemosiderosis

ArticleYear
Advances in respiratory therapeutics in children.
    Current opinion in pediatrics, 1993, Volume: 5, Issue:2

    A wide range of topics can be covered when considering a review of respiratory therapeutics. This review focuses on advances and controversies in the therapy of asthma, including issues regarding medications such as inhaled beta 2-agonists, inhaled corticosteroids, cromolyn sodium, and theophylline. Bronchodilator therapy for acute viral bronchiolitis remains a controversial issue and is discussed in light of recent published manuscripts. Issues regarding surfactant therapy for respiratory distress syndrome remain prominent in the neonatal respiratory therapeutics literature and recent findings in this area are reported. Advances in the treatment of cystic fibrosis, as well as a review concerning the pulmonary toxicity of various medications used in the treatment of pediatric illness are discussed.

    Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Inflammatory Agents; Asthma; Bronchiolitis, Viral; Bronchodilator Agents; Budesonide; Child; Cystic Fibrosis; Hemosiderosis; Humans; Infant, Newborn; Lung Diseases; Methotrexate; Pregnenediones; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Theophylline

1993

Other Studies

3 other study(ies) available for pulmicort and Hemosiderosis

ArticleYear
[Idiopathic pulmonary haemosiderosis in childhood: a good response to systemic steroids, inhaled hydroxychloroquine and budesonide].
    Archivos de bronconeumologia, 2010, Volume: 46, Issue:11

    Topics: Administration, Inhalation; Budesonide; Child; Glucocorticoids; Hemosiderosis; Hemosiderosis, Pulmonary; Humans; Hydroxychloroquine; Lung Diseases; Male; Prednisone

2010
Idiopathic pulmonary haemosiderosis--a case report.
    Singapore medical journal, 1998, Volume: 39, Issue:5

    Idiopathic pulmonary haemosiderosis (IPH) is a disorder characterised by the triad of haemoptysis, diffuse parenchymal infiltrates on chest roentgenogram and iron-deficiency anaemia. It is a diagnosis of exclusion and the prognosis is bleak despite the varied management options. We report a case of IPH occurring in a child who presented at four months of age with cough, wheeze, haemoptysis and pallor and whose symptoms are currently controlled with high-dose inhaled budesonide and low-dose oral prednisolone.

    Topics: Anti-Inflammatory Agents; Budesonide; Drug Therapy, Combination; Hemosiderosis; Humans; Infant; Lung Diseases; Male; Prednisolone; Prognosis

1998
Budesonide inhalation to treat idiopathic pulmonary haemosiderosis.
    Lancet (London, England), 1985, Apr-27, Volume: 1, Issue:8435

    Topics: Aerosols; Budesonide; Child; Female; Hemosiderosis; Humans; Lung Diseases; Pregnenediones

1985